Lunai Bioworks Nasdaq delisting: LNAI exits on Nov 12 with a $9.02M equity deficit, two reverse splits and no OTC quoting plan.
Sunshine Biopharma reverse stock split cuts shares 1-for-20 on October 26, 2026, to regain Nasdaq bid compliance. What changes, what does not.